OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection
Erin D. Michos, George L. Bakris, Helena W. Rodbard, et al.
American Journal of Preventive Cardiology (2023) Vol. 14, pp. 100502-100502
Open Access | Times Cited: 65
Erin D. Michos, George L. Bakris, Helena W. Rodbard, et al.
American Journal of Preventive Cardiology (2023) Vol. 14, pp. 100502-100502
Open Access | Times Cited: 65
Showing 26-50 of 65 citing articles:
Hypertension in chronic kidney disease and future heart failure
Michel Burnier
Current Opinion in Cardiology (2025)
Closed Access
Michel Burnier
Current Opinion in Cardiology (2025)
Closed Access
Emerging role of GLP-1 agonists in cardio-metabolic therapy - Focus on Semaglutide
Celestine I. Odigwe, Rajasekhar Mulyala, H. A. Malik, et al.
American Heart Journal Plus Cardiology Research and Practice (2025) Vol. 52, pp. 100518-100518
Open Access
Celestine I. Odigwe, Rajasekhar Mulyala, H. A. Malik, et al.
American Heart Journal Plus Cardiology Research and Practice (2025) Vol. 52, pp. 100518-100518
Open Access
Advances in incretin therapies for targeting cardiovascular disease in diabetes
Theresa L. Roberts, Dana S. Hutchinson, Denise Wootten, et al.
Journal of Molecular and Cellular Cardiology (2025)
Closed Access
Theresa L. Roberts, Dana S. Hutchinson, Denise Wootten, et al.
Journal of Molecular and Cellular Cardiology (2025)
Closed Access
Clinical Profile and Treatment Patterns in Individuals with Type 2 Diabetes and Chronic Kidney Disease Who Initiate a GLP-1 Receptor Agonist: A Multinational Cohort Study
Manel Pladevall, Ryan Ziemiecki, Catherine B. Johannes, et al.
Diabetes Therapy (2025)
Open Access
Manel Pladevall, Ryan Ziemiecki, Catherine B. Johannes, et al.
Diabetes Therapy (2025)
Open Access
Using guideline-directed medical therapies to improve kidney and cardiovascular outcomes in patients with chronic kidney disease
Thelma Barber, Joshua J. Neumiller, Michelle A. Fravel, et al.
American Journal of Health-System Pharmacy (2025)
Closed Access
Thelma Barber, Joshua J. Neumiller, Michelle A. Fravel, et al.
American Journal of Health-System Pharmacy (2025)
Closed Access
Metabolic, Renal, and Inflammatory Crosstalk in Atherosclerotic Cardiovascular Disease: Evolving Landscape and Future Directions
Harris Avgousti, Matthew J. Feinstein
Atherosclerosis (2025), pp. 119199-119199
Closed Access
Harris Avgousti, Matthew J. Feinstein
Atherosclerosis (2025), pp. 119199-119199
Closed Access
Novel Therapeutic Approaches in the Management of Chronic Kidney Disease
Bartłomiej Dąbek, Jill Dybiec, Weronika Frąk, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2746-2746
Open Access | Times Cited: 10
Bartłomiej Dąbek, Jill Dybiec, Weronika Frąk, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2746-2746
Open Access | Times Cited: 10
Rising to the challenge of cardio-renal-metabolic disease in the 21st century: Translating evidence into best clinical practice to prevent and manage atherosclerosis
Andrew J. Krentz, Stephan Jacob, Christian Heiß, et al.
Atherosclerosis (2024) Vol. 396, pp. 118528-118528
Closed Access | Times Cited: 3
Andrew J. Krentz, Stephan Jacob, Christian Heiß, et al.
Atherosclerosis (2024) Vol. 396, pp. 118528-118528
Closed Access | Times Cited: 3
Slowing the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes Using Four Pillars of Therapy: The Time to Act is Now
Panagiotis I. Georgianos, Vasilios Vaios, Theocharis Koufakis, et al.
Drugs (2024)
Closed Access | Times Cited: 3
Panagiotis I. Georgianos, Vasilios Vaios, Theocharis Koufakis, et al.
Drugs (2024)
Closed Access | Times Cited: 3
Efficacy of Chronic Use of Sodium–Glucose Co-transporter 2 Inhibitors on the Prevention of Contrast-Induced Acute Kidney Injury in Patients with Type 2 Diabetes Mellitus Following Coronary Procedures: A Systematic Review and Meta-Analysis
Kyriakos Dimitriadis, Angeliki Vakka, Nikolaos Pyrpyris, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access | Times Cited: 3
Kyriakos Dimitriadis, Angeliki Vakka, Nikolaos Pyrpyris, et al.
American Journal of Cardiovascular Drugs (2024)
Closed Access | Times Cited: 3
Impact of ADA Guidelines and Medication Shortage on GLP-1 Receptor Agonists Prescribing Trends in the UK: A Time-Series Analysis with Country-Specific Insights
Ahmed R. N. Ibrahim, Khalid Orayj
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6256-6256
Open Access | Times Cited: 3
Ahmed R. N. Ibrahim, Khalid Orayj
Journal of Clinical Medicine (2024) Vol. 13, Iss. 20, pp. 6256-6256
Open Access | Times Cited: 3
Incretin-based therapies for the treatment of obesity-related diseases
Irene Caruso, Angelo Cignarelli, Gian Pio Sorice, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Irene Caruso, Angelo Cignarelli, Gian Pio Sorice, et al.
npj Metabolic Health and Disease (2024) Vol. 2, Iss. 1
Open Access | Times Cited: 3
Visceral adipose tissue and risk of diabetic nephropathy: A Mendelian randomization study
Min Tao, Guanghong Zhou, Jing Liu, et al.
Diabetes Research and Clinical Practice (2024) Vol. 209, pp. 111586-111586
Closed Access | Times Cited: 2
Min Tao, Guanghong Zhou, Jing Liu, et al.
Diabetes Research and Clinical Practice (2024) Vol. 209, pp. 111586-111586
Closed Access | Times Cited: 2
GLP-1 in hypothalamic paraventricular nucleus promotes sympathetic activation and hypertension
Xiaoyu Xu, Jing-Xiao Wang, Jun-Liu Chen, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 21, pp. e2032232024-e2032232024
Closed Access | Times Cited: 2
Xiaoyu Xu, Jing-Xiao Wang, Jun-Liu Chen, et al.
Journal of Neuroscience (2024) Vol. 44, Iss. 21, pp. e2032232024-e2032232024
Closed Access | Times Cited: 2
Rediscovery of the implication of albuminuria in heart failure: emerging classic index for cardiorenal interaction
Kyung‐Duk Min, Yuki Matsumoto, Masanori Asakura, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 6, pp. 3470-3487
Open Access | Times Cited: 2
Kyung‐Duk Min, Yuki Matsumoto, Masanori Asakura, et al.
ESC Heart Failure (2024) Vol. 11, Iss. 6, pp. 3470-3487
Open Access | Times Cited: 2
The impact of GLP-1 signalling on the energy metabolism of pancreatic islet β-cells and extrapancreatic tissues
Leah A. Peart, Matthew Draper, Andrei I. Tarasov
Peptides (2024) Vol. 178, pp. 171243-171243
Closed Access | Times Cited: 2
Leah A. Peart, Matthew Draper, Andrei I. Tarasov
Peptides (2024) Vol. 178, pp. 171243-171243
Closed Access | Times Cited: 2
Newer Glucose-Lowering Drugs and Risk of Gout: A Network Meta-Analysis of Randomized Outcomes Trials
Aihua Wang, Weilong Shi, Ning Zhang, et al.
Clinical Therapeutics (2024) Vol. 46, Iss. 11, pp. 851-854
Closed Access | Times Cited: 2
Aihua Wang, Weilong Shi, Ning Zhang, et al.
Clinical Therapeutics (2024) Vol. 46, Iss. 11, pp. 851-854
Closed Access | Times Cited: 2
Environmental factors related to the origin and evolution of differentiated thyroid cancer: a narrative review
José Paz‐Ibarra, Marcio José Concepción‐Zavaleta, Juan Eduardo Quiroz‐Aldave
Expert Review of Endocrinology & Metabolism (2024) Vol. 19, Iss. 6, pp. 469-477
Closed Access | Times Cited: 2
José Paz‐Ibarra, Marcio José Concepción‐Zavaleta, Juan Eduardo Quiroz‐Aldave
Expert Review of Endocrinology & Metabolism (2024) Vol. 19, Iss. 6, pp. 469-477
Closed Access | Times Cited: 2
A new perspective on proteinuria and drug therapy for diabetic kidney disease
Ruimin Zhang, Qian Wang, Yaqing Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Ruimin Zhang, Qian Wang, Yaqing Li, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Optimization of guideline-directed medical therapies in patients with diabetes and chronic kidney disease
Joshua J. Neumiller, Radica Z. Alicic, Katherine R. Tuttle
Clinical Kidney Journal (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Joshua J. Neumiller, Radica Z. Alicic, Katherine R. Tuttle
Clinical Kidney Journal (2023) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Use of continuous glucose monitoring when initiating glucagon‐like peptide ‐1 receptor agonist therapy in insulin‐treated diabetes
Irl B. Hirsch, Christopher G. Parkin, Tricia Santos Cavaiola, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S7, pp. 17-26
Closed Access | Times Cited: 1
Irl B. Hirsch, Christopher G. Parkin, Tricia Santos Cavaiola, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. S7, pp. 17-26
Closed Access | Times Cited: 1
Effect of GLP-1 Receptor Agonists on Renal Functions and Diabetic Nephropathy in Type 2 Diabetes Mellitus (T2DM) Patients: A Systematic Review and Meta-Analysis
Ali Mohamed, Ali Al-Saffar, Ali Mohamed, et al.
Cureus (2024)
Open Access | Times Cited: 1
Ali Mohamed, Ali Al-Saffar, Ali Mohamed, et al.
Cureus (2024)
Open Access | Times Cited: 1
Glucagon-like Peptide 1 Receptor Agonists in Cardio-Oncology: Pathophysiology of Cardiometabolic Outcomes in Cancer Patients
Vincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11299-11299
Open Access | Times Cited: 1
Vincenzo Quagliariello, Maria Laura Canale, Irma Bisceglia, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 20, pp. 11299-11299
Open Access | Times Cited: 1
GLP‐1 Receptor Agonists Alleviate Diabetic Kidney Injury via β‐Klotho‐Mediated Ferroptosis Inhibition
Shasha Tian, Saijun Zhou, Weixi Wu, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
Shasha Tian, Saijun Zhou, Weixi Wu, et al.
Advanced Science (2024)
Open Access | Times Cited: 1
DETERMINANTS OF 1-YEAR MORTALITY AFTER ACUTE MYOCARDIAL INFARCTION IN SUBJECTS WITH AND WITHOUT DIABETES
Annalisa Montebello, Martina Agius, Martina Grech, et al.
Clinical Medicine (2024) Vol. 24, Iss. 4, pp. 100223-100223
Open Access
Annalisa Montebello, Martina Agius, Martina Grech, et al.
Clinical Medicine (2024) Vol. 24, Iss. 4, pp. 100223-100223
Open Access
